Article Type
Changed
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application

Article PDF
Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Issue
The American Journal of Orthopedics - 37(11)
Publications
Topics
Page Number
572-574
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Sections
Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Author and Disclosure Information

David M. Kalainov, MD, and Leonard A. Valentino, MD

Dr. Kalainov is Assistant Professor, Clinical Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Dr. Valentino is Associate Professor, Pediatrics and Internal Medicine, and Director, Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois.

Article PDF
Article PDF

Issue
The American Journal of Orthopedics - 37(11)
Issue
The American Journal of Orthopedics - 37(11)
Page Number
572-574
Page Number
572-574
Publications
Publications
Topics
Article Type
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application
Display Headline
Recombinant Activated Factor VII as a Temporary Reversal Agent for Warfarin Anticoagulation: A Cautionary Report on an Off-Label Application
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Legacy Keywords
recombinant activated factor VII, warfarin, anticoagulation, thromboembolism, pulmonary emboli, vitamin k antagonist, shoulder, off label, application, ajo, american journal of orthopedics
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media